BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Y, Yang Z, Wang Y, Wang J, Wang C. Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer. BMC Cancer 2019;19:651. [PMID: 31269908 DOI: 10.1186/s12885-019-5850-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Freitas MO, Gartner J, Rangel-Pozzo A, Mai S. Genomic Instability in Circulating Tumor Cells. Cancers (Basel) 2020;12:E3001. [PMID: 33081135 DOI: 10.3390/cancers12103001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ge L, Song Y, Yang F, Zhao G, Lu M, Zhang S, Ma L. Clinical significance of circulating tumor cells detection in renal cell carcinoma with thrombus: A STROBE-compliant study. Medicine (Baltimore) 2020;99:e20615. [PMID: 32481476 DOI: 10.1097/MD.0000000000020615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Tayoun T, Oulhen M, Aberlenc A, Farace F, Pawlikowska P. Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability. Cells 2021;10:337. [PMID: 33562741 DOI: 10.3390/cells10020337] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Hong Y, Si J, Zhang J, Xiong Y, Zhang J, Lin PP, Fang J, Yang Y, Lv C, Ma Y. Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer. Front Oncol 2021;11:590952. [PMID: 33747909 DOI: 10.3389/fonc.2021.590952] [Reference Citation Analysis]
5 Shoda K, Saito R, Maruyama S, Furuya S, Akaike H, Kawaguchi Y, Amemiya H, Kawaida H, Sudo M, Inoue S, Kono H, Ichikawa D. Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature. Surg Today 2021;51:849-61. [PMID: 32979121 DOI: 10.1007/s00595-020-02148-7] [Reference Citation Analysis]